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Boot et al. describe a case of hepatitis B vaccination
failure in a healthcare worker [1]. According to this re-
port, the case belongs to two risk groups for hepatitis
B virus (HBV) infection: healthcare workers and male
homosexuals. The report presents a history of unsafe
sex with at least ﬁve male partners in the six months
prior to the acute infection and no details about occupa-
tional exposures. In addition, the molecular epidemiol-
ogy is that of a HBV isolate prevalent among men
who have sex with men (MSM) in the Netherlands.
The authors state that ‘‘Healthcare workers [HCWs]
whose response to the initial hepatitis B vaccination is
moderate might be vulnerable to hepatitis B virus infec-
tion”. However, this case report is not about occupa-
tionally acquired hepatitis B infection but rather about
sexually transmitted infection from sexual exposure.
Furthermore, there are host factors that indicate some
immunological dysfunction. The patient had ‘‘re-
sponded only marginally” to his primary vaccination
series (anti-HBs = 10 sample ratio units). In addition,
the patient had a reverse CD4:CD8 ratio with decreased
T-cell responsiveness against mitogens.
Hepatitis B vaccine provides at least 15 years of pro-
tection, as demonstrated in a randomized controlled
trial of children vaccinated at birth [2], and at least 10
years of protection in HCWs [3]. Policy makers shouldAcute hepatitis B in a healthcar
of failure of hepatcontinue to be vigilant about the potential for break-
through infections, however, they should also remain as-
sured of the excellent performance of this vaccine in the
occupational health setting. Behavior change should
continue to be seen as an important protective measure
in MSM, especially when immune dysfunction could
blunt the response to vaccination.
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itis B vaccinationTo the Editor:
In response to our case report of an acute HBV infec-
tion in a vaccinated male nurse [1], Dr. S. Wiersma of
the WHO [2] argues that our patient had multiple
HBV exposure risks, and that HBV acquisition via the
hospital setting is less likely than acquisition via sexual
exposure in this particular case. We agree with his view
that unsafe homosexual contacts in the months preced-
ing the acute HBV infection are the most likely source
of infection. However, it is not the source of infection
that is the important issue here, but the fact that a fully
vaccinated person, registered as being HBV protected,
can be a source of HBV transmission to others, and, if
the person is a healthcare worker, a source within a hos-
pital. We agree that, at the moment, there is no need torevise the policy for healthcare-speciﬁc HB vaccination.
However, as also stated by Dr. Wiersma [2], we must be
aware of the fact that vaccinees, including healthcare
workers, might become infected with HBV despite a
documented adequate response to an HB vaccine in
the past. This might become a more prominent feature
when individuals who were vaccinated against HBV as
neonates start working in the healthcare setting. If and
why this speciﬁc patient was predisposed to become
HBV infected remains unclear. Were his poor-to-moder-
ate responses to the successive HB-plasma vaccines the
reason for his vulnerability, or is his unbalanced im-
mune response involved, or is it a combination of both?
As we have stressed in the Discussion section of our pa-
per [1], it is not easy to recognize secondaryHBvaccination
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over 5% of adult vaccinees. Not only awareness that vac-
cine-induced immunity against HBV can wane over time,
but also awareness of which factors are associated with
waning immunity is important for preventing HBV infec-
tion in general and in the healthcare setting in particular.
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Towards a better liver allocation systemTo the Editor:
We read with great interest the Twelfth Forum on
Liver Transplantation published in Journal ofHepatology
[1]. Although we agree that theMELD score is basically a
‘‘justice system” which allocates patients according to
severity of liver disease however it is not necessarily the
best system [2] and indeed some limitations of theMELD
score were totally ignored in the forummentioned above.
For example, signiﬁcant variations of the MELD score
have been found using diﬀerent laboratory methodolo-
gies for INR measurement [3], as well as creatinine (Cr)
as we have published [4], and recently MELD-Na [5].
These variations, which may be cumulative when sum-
mated, lead to inequalities in prioritization of candidates,
especially in those with the highest priority for LT (more
jaundiced, greater renal dysfunction and lower serum so-
dium). A system of allocation that inherently does not
have standardized measurements cannot reﬂect true jus-
tice for individuals on waiting lists – this needs to be ad-
dressed. Moreover, there is an issue of potential gender
bias, highlighted by us [6] and reported by Moylan et al.
[7]. In the UNOS database, women were more likely to
die on the waiting list in the post-MELD era, compared
to the pre-MELD era, although women were listed with
lower median MELD scores, compared to men (14 vs.15, p < 0.001). These ﬁndings are likely to be the result
of not considering lower Cr in women for the same renal
function (GFR), as in men [8], as we documented in our
paper [6]. Interestingly, we found that correcting Cr by
equalising the GFR between men and women resulted
in an increase in MELD score by 2 or 3 points in 65%
of female LT candidates [6]. Our ﬁndings with Cr are also
pertinent to ethnicity diﬀerences. South Asian candidates
have worse GFR for the same Cr values than Caucasians,
and the opposite is true for black Africans, whether
Americans or otherwise. A correction factor for gender
and ethnicity could be introduced [6].
Regarding post-LT survival, it is true that the
MELD score is a weak predictor of mortality after
LT, so it cannot be used as a predictor. In order to as-
sess likelihood of a good outcome, we have proposed a
MELDD score – a second D for donor [2,8]. This
would allow a utilitarian approach to allocation on
top of the ‘‘solely justice approach” of MELD and
would lead to a transplant beneﬁt model for allocation.
A recent evaluation of the European Liver Transplant
Registry data [9], demonstrated that donor age, total
ischaemic time, and other operative and recipient fac-
tors, not included in MELD, signiﬁcantly and indepen-
dently impacted on outcomes post-LT with very good
